George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), sold 6,000 shares at $3.37 ($20K) on 2021-03-02, disclosed to the SEC on 2021-03-03.
Scheduled sale ($20k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLSD | SELL | 2022-01-20 | $23K | — | Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |